These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 32725890)

  • 41. Abnormal liver tests in patients with SARS-CoV-2 or influenza - prognostic similarities and temporal disparities.
    Shafran N; Issachar A; Shochat T; Shafran IH; Bursztyn M; Shlomai A
    JHEP Rep; 2021 Jun; 3(3):100258. PubMed ID: 33644724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does Raised Transaminases Predict Severity and Mortality in Patients with COVID 19?
    Kodavoor Vadiraj P; Thareja S; Raman N; Karantha SC; Jayaraman M; Vardhan V
    J Clin Exp Hepatol; 2022; 12(4):1114-1123. PubMed ID: 35125781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal liver-related biomarkers in COVID-19 patients and the role of prealbumin.
    Li T; Guo Y; Zhuang X; Huang L; Zhang X; Wei F; Yang B
    Saudi J Gastroenterol; 2020; 26(5):272-278. PubMed ID: 32769260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sources and clinical significance of aspartate aminotransferase increases in COVID-19.
    Aloisio E; Colombo G; Arrigo C; Dolci A; Panteghini M
    Clin Chim Acta; 2021 Nov; 522():88-95. PubMed ID: 34411557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Faruqui S; Okoli FC; Olsen SK; Feldman DM; Kalia HS; Park JS; Stanca CM; Figueroa Diaz V; Yuan S; Dagher NN; Sarkar SA; Theise ND; Kim S; Shanbhogue K; Jacobson IM
    Am J Gastroenterol; 2021 Jul; 116(7):1414-1425. PubMed ID: 33993134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020 : A Cross-Sectional Study.
    Garg S; Patel K; Pham H; Whitaker M; O'Halloran A; Milucky J; Anglin O; Kirley PD; Reingold A; Kawasaki B; Herlihy R; Yousey-Hindes K; Maslar A; Anderson EJ; Openo KP; Weigel A; Teno K; Ryan PA; Monroe ML; Reeg L; Kim S; Como-Sabetti K; Bye E; Shrum Davis S; Eisenberg N; Muse A; Barney G; Bennett NM; Felsen CB; Billing L; Shiltz J; Sutton M; Abdullah N; Talbot HK; Schaffner W; Hill M; Chatelain R; Wortham J; Taylor C; Hall A; Fry AM; Kim L; Havers FP
    Ann Intern Med; 2021 Oct; 174(10):1409-1419. PubMed ID: 34370517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.
    Xie H; Zhao J; Lian N; Lin S; Xie Q; Zhuo H
    Liver Int; 2020 Jun; 40(6):1321-1326. PubMed ID: 32239591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coronavirus disease (COVID-19) and the liver: a comprehensive systematic review and meta-analysis.
    Kumar-M P; Mishra S; Jha DK; Shukla J; Choudhury A; Mohindra R; Mandavdhare HS; Dutta U; Sharma V
    Hepatol Int; 2020 Sep; 14(5):711-722. PubMed ID: 32623633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of COVID-19 on the liver: The experience of a single center.
    Liakina V; Stundiene I; Milaknyte G; Bytautiene R; Reivytyte R; Puronaite R; Urbanoviciute G; Kazenaite E
    World J Gastroenterol; 2022 Oct; 28(39):5735-5749. PubMed ID: 36338891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil.
    Pozzobon FM; Perazzo H; Bozza FA; Rodrigues RS; de Mello Perez R; Chindamo MC
    Hepatol Int; 2021 Apr; 15(2):493-501. PubMed ID: 33534084
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID-19): U.S. Multicenter Experience.
    Rabiee A; Sadowski B; Adeniji N; Perumalswami PV; Nguyen V; Moghe A; Latt NL; Kumar S; Aloman C; Catana AM; Bloom PP; Chavin KD; Carr RM; Dunn W; Chen VL; Aby ES; Debes JD; Dhanasekaran R;
    Hepatology; 2020 Dec; 72(6):1900-1911. PubMed ID: 32964510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association between markers of liver injury and clinical outcomes in patients with COVID-19 in Wuhan.
    Huang H; Chen S; Li H; Zhou XL; Dai Y; Wu J; Zhang J; Shao L; Yan R; Wang M; Wang J; Tu Y; Ge M
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1051-1059. PubMed ID: 32697870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.
    Ip A; Berry DA; Hansen E; Goy AH; Pecora AL; Sinclaire BA; Bednarz U; Marafelias M; Berry SM; Berry NS; Mathura S; Sawczuk IS; Biran N; Go RC; Sperber S; Piwoz JA; Balani B; Cicogna C; Sebti R; Zuckerman J; Rose KM; Tank L; Jacobs LG; Korcak J; Timmapuri SL; Underwood JP; Sugalski G; Barsky C; Varga DW; Asif A; Landolfi JC; Goldberg SL
    PLoS One; 2020; 15(8):e0237693. PubMed ID: 32790733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical efficacy and safety of different antiviral regimens in patients with coronavirus disease 2019].
    Gao X; Ma C; Ma Y; Wang X; Wei J; Feng T; Zhao G; Xu L; Zhou W; Zheng X; Zhao Q; Cao X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1423-1427. PubMed ID: 33541491
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alteration in liver function tests among patients hospitalized for COVID-19: a multicentric study in Peru.
    Marín-Dueñas I; Vega J; Carrillo-Ng H; Veramendi-Schult I; Zavaleta-Alva R; Vásquez-Elera L; Gonzales-Soler Z; Agurto HS; Tarrillo-Purisaca J; Garavito-Rentería J; Lozano-Miranda A
    Rev Gastroenterol Peru; 2021; 41(2):86-93. PubMed ID: 34724689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
    Li Y; Shang Y; Yang Y; Wang M; Yu D; Su D; Liu L; Wang Q; Zhang X; Ren J; Chen H
    Respiration; 2020; 99(9):739-747. PubMed ID: 33207356
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury.
    Siddiqui MA; Suresh S; Simmer S; Abu-Ghanimeh M; Karrick M; Nimri F; Musleh M; Mediratta V; Al-Shammari M; Russell S; Jou J; Dang D; Salgia R; Zuchelli T
    Dig Dis Sci; 2022 Jun; 67(6):2577-2583. PubMed ID: 33945064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SARS-CoV-2 Infection Induces a Dual Response in Liver Function Tests: Association with Mortality during Hospitalization.
    Bernal-Monterde V; Casas-Deza D; Letona-Giménez L; de la Llama-Celis N; Calmarza P; Sierra-Gabarda O; Betoré-Glaria E; Martínez-de Lagos M; Martínez-Barredo L; Espinosa-Pérez M; M Arbones-Mainar J
    Biomedicines; 2020 Sep; 8(9):. PubMed ID: 32899640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.